US Stock MarketDetailed Quotes

PRQR ProQR Therapeutics

Watchlist
  • 3.6200
  • +0.0100+0.28%
Close Nov 22 16:00 ET
  • 3.6200
  • 0.00000.00%
Post 16:00 ET
383.38MMarket Cap-11528P/E (TTM)

About ProQR Therapeutics Company

ProQR Therapeutics NV is a clinical stage biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases. The company was founded by Daniel Anton de Boer, Gerard J. Platenburg, Henri A. Termeer, and Domenico Valerio on February 21, 2012, and is headquartered in Leiden, the Netherlands.

Company Profile

SymbolPRQR
Company NameProQR Therapeutics
Listing DateSep 18, 2014
Issue Price13.00
Founded2012
CEOMr. Daniel de Boer
MarketNASDAQ
Employees157
Fiscal Year Ends12-31
AddressZernikedreef 9
CityLeiden
ProvinceZuid-Holland
CountryNetherlands (the)
Zip Code2333 CK
Phone31-88-166-70-00
Websitehttp://www.proqr-tx.com

Company Executives

  • Name
  • Position
  • Salary
  • Daniel de Boer
  • Chief Executive Officer
  • 2.44M
  • Jurriaan Dekkers
  • Chief Financial Officer
  • --
  • Gerard Platenburg
  • Chief Scientific Officer
  • --
  • Rene Beukema
  • Chief Corporate Development Officer and General Counsel
  • 1.31M
  • Sheila Sponselee
  • Chief People and Operations Officer
  • --
  • Dinko Valerio
  • Chairman of the Supervisory Board
  • 150.00K
  • Dr. Begoña Carreño
  • Member of the Supervisory Board
  • 84.00K
  • Alison F. Lawton
  • Member of the Supervisory Board
  • 126.00K
  • Dr. James S. Shannon, M.D.,M.R.C.P.
  • Member of the Supervisory Board
  • 132.00K
  • Theresa M. Heggie
  • Member of the Supervisory Board
  • 271.00K
  • Bart Filius, M.B.A.
  • Member of the Supervisory Board
  • 127.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data